Shandong Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SHANDONG, and what generic alternatives to SHANDONG drugs are available?
SHANDONG has thirteen approved drugs.
There are five US patents protecting SHANDONG drugs. There is one tentative approval on SHANDONG drugs.
There are twenty-nine patent family members on SHANDONG drugs in fourteen countries and forty-one supplementary protection certificates in eleven countries.
Summary for Shandong
| International Patents: | 29 |
| US Patents: | 5 |
| Tradenames: | 11 |
| Ingredients: | 11 |
| NDAs: | 13 |
Drugs and US Patents for Shandong
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shandong | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 207375-004 | May 7, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Shandong | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 207375-003 | May 7, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Shandong | PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 204959-003 | Aug 10, 2018 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Shandong Luye | RYKINDO | risperidone | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 212849-001 | Jan 13, 2023 | RX | Yes | No | 11,110,094 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Shandong | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 207375-002 | May 7, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Shandong Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 3199146 | ⤷ Subscribe |
| Spain | 2607497 | ⤷ Subscribe |
| Portugal | 2701687 | ⤷ Subscribe |
| Hungary | E032310 | ⤷ Subscribe |
| European Patent Office | 3772354 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Shandong Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0716606 | 6/2002 | Austria | ⤷ Subscribe | PRODUCT NAME: SEVELAMER SOWIE DESSEN PHARMAZEUTISCH VERTRAEGLICHEN SALZE; REGISTRATION NO/DATE: EU/1/99/123/001 - EU/1/99/123/004 20000128 |
| 0716606 | C300080 | Netherlands | ⤷ Subscribe | PRODUCT NAME: SEVELAMER, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZOUT, IN HET BIJZONDER SEVELAMER HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/99/123/001-00420000128 20000128 |
| 0247633 | 62/1997 | Austria | ⤷ Subscribe | PRODUCT NAME: ATORVASTATIN CALCIUM; NAT. REGISTRATION NO/DATE: 1-21926, 1-21927, 1-21928 19970411; FIRST REGISTRATION: GB PL 00018/0240 - PL 00018/0242 19961107 |
| 0720599 | 92544 | Luxembourg | ⤷ Subscribe | PRODUCT NAME: EZETIMIBE EN COMBINAISON AVEC ROSUVASTATINE OU LEURS SELS PHARMACEUTIQUEMENT ACCEPTEES, Y COMPRIS ROSUVASTATINE SOUD FORME DE SEL DE ZINC; FIRST REGISTRATION DATE: 20140724 |
| 0716606 | SPC/GB02/011 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: SEVELAMER; REGISTERED: UK EU/1/99/120/001-004 20000202 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
